{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:35:12Z","timestamp":1740123312316,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-023-02880-2","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T12:02:31Z","timestamp":1697457751000},"page":"4791-4795","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Canalicular obstruction associated with dupilumab"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3450-1183","authenticated-orcid":false,"given":"Allan Z.","family":"Nghiem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahreen","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolas","family":"Koutroumanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"2880_CR1","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"M de Bruin-Weller","year":"2018","unstructured":"de Bruin-Weller M, Tha\u00e7i D, Smith CH et al (2018) Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAF\u00c9). Br J Dermatol 178:1083\u20131101. https:\/\/doi.org\/10.1111\/bjd.16156","journal-title":"Br J Dermatol"},{"key":"2880_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/bjd.17869","volume":"181","author":"B Akinlade","year":"2019","unstructured":"Akinlade B, Guttman-Yassky E, de Bruin-Weller M et al (2019) Conjunctivitis in dupilumab clinical trials. Br J Dermatol 181:459\u2013473. https:\/\/doi.org\/10.1111\/bjd.17869","journal-title":"Br J Dermatol"},{"key":"2880_CR3","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E et al (2016) Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 375:2335\u20132348. https:\/\/doi.org\/10.1056\/NEJMoa1610020","journal-title":"N Engl J Med"},{"key":"2880_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2019.07.074","volume":"82","author":"M Deleuran","year":"2020","unstructured":"Deleuran M, Tha\u00e7i D, Beck LA et al (2020) Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study. J Am Acad Dermatol 82:377\u2013388. https:\/\/doi.org\/10.1016\/j.jaad.2019.07.074","journal-title":"J Am Acad Dermatol"},{"key":"2880_CR5","doi-asserted-by":"crossref","unstructured":"Tauqeer Z, Jinno SE, Chung CW, et al (2022) Clinical characteristics and treatment for dupilumab-related ocular complications in atopic dermatitis patients","DOI":"10.2147\/OPTH.S336978"},{"key":"2880_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/09546634.2019.1711010","volume":"32","author":"DH Lee","year":"2020","unstructured":"Lee DH, Cohen LM, Yoon MK et al (2020) Punctal stenosis associated with dupilumab therapy for atopic dermatitis Punctal stenosis associated with dupilumab therapy for atopic dermatitis. J Dermatolog Treat 32:737\u2013740. https:\/\/doi.org\/10.1080\/09546634.2019.1711010","journal-title":"J Dermatolog Treat"},{"key":"2880_CR7","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1038\/s41433-020-01379-9","volume":"35","author":"MZ Popiela","year":"2021","unstructured":"Popiela MZ, Barbara R, Turnbull AMJ et al (2021) Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae. Eye 35:3277\u20133284. https:\/\/doi.org\/10.1038\/s41433-020-01379-9","journal-title":"Eye"},{"key":"2880_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/aos.14762","volume":"99","author":"MG Fiorino","year":"2021","unstructured":"Fiorino MG, Quaranta-Leoni C, Quaranta-Leoni FM (2021) Proximal lacrimal obstructions: a review. Acta Ophthalmol 99:701\u2013711. https:\/\/doi.org\/10.1111\/aos.14762","journal-title":"Acta Ophthalmol"},{"key":"2880_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/IOP.0000000000000745","volume":"33","author":"C Mansur","year":"2017","unstructured":"Mansur C, Pfeiffer ML, Esmaeli B (2017) Evaluation and Management of Chemotherapy-Induced Epiphora, Punctal and Canalicular Stenosis, and Nasolacrimal Duct Obstruction. Ophthal Plast Reconstr Surg 33:9\u201312. https:\/\/doi.org\/10.1097\/IOP.0000000000000745","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"2880_CR10","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s00117-008-1692-z","volume":"48","author":"M L\u00fcchtenberg","year":"2008","unstructured":"L\u00fcchtenberg M, Berkefeld J, Bink A (2008) Presaccal stenosis as a cause of epiphora. Radiologe 48:1164\u20131168. https:\/\/doi.org\/10.1007\/s00117-008-1692-z","journal-title":"Radiologe"},{"key":"2880_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1684\/ejd.2021.4180","volume":"31","author":"L Loret","year":"2021","unstructured":"Loret L, Ninclaus V, Dendooven A et al (2021) Canalicular stenosis associated with dupilumab treatment for atopic dermatitis. Eur J Dermatol 31:843\u2013844. https:\/\/doi.org\/10.1684\/ejd.2021.4180","journal-title":"Eur J Dermatol"},{"key":"2880_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/s0002-9394(14)76849-7","volume":"112","author":"GC Sekhar","year":"1991","unstructured":"Sekhar GC, Dortzbach RK, Gonnering RS, Lemke BN (1991) Problems associated with conjunctivodacryocystorhinostomy. Am J Ophthalmol 112:502\u2013506. https:\/\/doi.org\/10.1016\/s0002-9394(14)76849-7","journal-title":"Am J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02880-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-023-02880-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02880-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:09:09Z","timestamp":1702652949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-023-02880-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":12,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2880"],"URL":"https:\/\/doi.org\/10.1007\/s10792-023-02880-2","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}